Core One Labs Inc (CLABF)
0.1072
-0.01
(-9.92%)
USD |
OTCM |
Jun 21, 14:48
Core One Labs Shareholders Equity (Quarterly): 4.252M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.252M |
| September 30, 2023 | 4.443M |
| September 30, 2022 | 3.926M |
| June 30, 2022 | 3.726M |
| March 31, 2022 | 3.168M |
| December 31, 2021 | 3.379M |
| September 30, 2021 | 3.405M |
| June 30, 2021 | 3.448M |
| March 31, 2021 | 5.038M |
| December 31, 2020 | 4.229M |
| September 30, 2020 | 9.611M |
| June 30, 2020 | 6.040M |
| March 31, 2020 | 4.962M |
| December 31, 2019 | 5.535M |
| September 30, 2019 | 13.96M |
| June 30, 2019 | 17.56M |
| March 31, 2019 | 15.40M |
| December 31, 2018 | 13.05M |
| September 30, 2018 | 16.19M |
| June 30, 2018 | 17.35M |
| March 31, 2018 | 11.81M |
| December 31, 2017 | 9.087M |
| June 30, 2017 | 8.036M |
| March 31, 2017 | 1.359M |
| Date | Value |
|---|---|
| December 31, 2016 | 1.050M |
| September 30, 2016 | 1.171M |
| June 30, 2016 | 0.3487M |
| March 31, 2016 | 0.5006M |
| December 31, 2015 | 0.7621M |
| September 30, 2015 | 1.226M |
| June 30, 2015 | 1.575M |
| March 31, 2015 | -0.076M |
| December 31, 2014 | -0.0083M |
| September 30, 2014 | -0.0402M |
| June 30, 2014 | 0.0691M |
| March 31, 2014 | 0.0104M |
| December 31, 2013 | 0.0642M |
| September 30, 2013 | 0.137M |
| June 30, 2013 | 0.2146M |
| March 31, 2013 | 0.4302M |
| December 31, 2012 | 0.5128M |
| September 30, 2012 | 0.5952M |
| June 30, 2012 | 0.6367M |
| March 31, 2012 | 0.7458M |
| December 31, 2011 | 0.8042M |
| September 30, 2011 | 0.8423M |
| June 30, 2011 | 0.3475M |
| March 31, 2011 | 0.3899M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.168M
Minimum
Mar 2022
17.56M
Maximum
Jun 2019
6.042M
Average
4.348M
Median
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| InMed Pharmaceuticals Inc | 11.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.578M |
| Total Liabilities (Quarterly) | 1.326M |
| Debt to Equity Ratio | 0.0443 |
| Current Ratio | 0.2534 |
| Net Debt Paydown Yield | -0.29% |